Quick answers
- What is RiVive?
- RiVive is a brand name of Naloxone, an over-the-counter medicine. The FDA NDC Directory lists 1 RiVive product in 1 strength and form.
- Who makes RiVive?
- Harm Reduction Therp holds the FDA application for RiVive (NDA217722, approved July 28, 2023).
- Is there a generic or store brand of RiVive?
- Other products of Naloxone are listed with the FDA, but none in exactly the same strength and form as a RiVive product.
- Has RiVive been recalled?
- No recall linked to RiVive products (by their NDC code or label) appears in the FDA enforcement reports we use.
What RiVive is
Each RiVive product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Naloxone · over-the-counter medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| naloxone hydrochloride 3 mg/0.1 mL spray (nasal) | RiVive | None listed | DailyMed |
Its page quotes the Drug Facts label and lists every brand and store brand: Naloxone →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA217722 | Harm Reduction Therp | July 28, 2023 | 1 |
Companies that list RiVive
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of RiVive products.
- Harm Reduction Therapeutics, Inc.1 product
Recalls
No recall linked to RiVive products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.